Inhibitor refers to substance that can hinder the chemical reactions, biological reactions (including immune response) and biological activity. In present time, commonly used inhibitors include immunosuppressants and inhibitors. 1. Immunosuppressive agents: immunosuppressants system refers to drug that can reduce the immune response. It can selectively suppress certain steps of the immune response and immune cells. Immune response refers to the body’s response to a variety of pathogenic substances. Some reactions are favorable to the body and can enhance the body's resistance to disease; some have adverse effects on the body and can cause tissue damage or disorders of physiological functions (allergy). Therefore, patients suffering from allergic reactions being harmful to the body should be subject to the treatment of immunosuppressant to affect the related immune processes and reduce the immune response of the body. For the treatment of various autoimmune diseases and weakening the tissue incompatibility, it has been developed of a variety of immunosuppressive agents, some of which have been widely used in clinical practice. Commonly used immunosuppressants include glucocorticoids (prednisone, prednisolone, etc.), alkylating agents (nitric oxide mustard, cyclophosphamide, thiotepa, busulfan, etc.), and antimetabolites (6- mercaptopurine, azathioprine, methotrexate, etc.). The mechanism of immunosuppressants, though not entirely clear, but is characterized by the following several aspects: ① most kinds of immunosuppressants can simultaneously inhibit cellular and humoral immunity and can be used for organ transplantation and autoimmune disease. ②Its inhibitory effect is strong for the primary immune response while the inhibitory effect against secondary response is weak. ③It can simultaneously act on normal and pathological immunity, therefore, can often lead to some complications. ④These drugs often have strong with serious adverse reactions. 2. Enzyme
Carfilzomib: Chemical property, Mechanism of action, and Clinical studies
Carfilzomib (also known as PR-171) is an epoxomicin-based proteasome inhibitor with improved pharmaceutical properties.
Nov 22,2024 InhibitorsA hyaluronic acid biosynthesis inhibitor: 4-Methylumbelliferone
4-Methylumbelliferone (4MU) is a hyaluronic acid biosynthesis inhibitor with antitumoral and antimetastatic effects
Jul 10,2024 InhibitorsPralsetinib: Indications, Mechanism of action and Side Effects
Pralsetinib is a kinase inhibitor that targets wild-type RET and kinase-activated RET mutations and fusions.
Jun 25,2024 Inhibitors2-Deoxy-D-glucose: a competitive inhibitor of glycolysis
2-Deoxy-D-glucose (2-DG, 2-deoxy-D-arabino-hexopyranose) is a natural, nonmetabolizable glucose analogue and a competitive glycolysis inhibitor.
Jun 20,2024 InhibitorsQ:Is telmisartan the same as losartan?
A:The most often prescribed ARBs are telmisartan and losartan. Both drugs are ARBs. However, they are different.
Jun 11,2024 InhibitorsMechanisms of resistance to ABT-199 in leukemia and lymphoma cell lines
ABT-199 (Venetoclax) is a potent, orally bioavailable, selective inhibitor of BCL-2. It is approved for the treatment of first-line and relapsed/refractory chronic lymphocytic leukaemia (CLL) and acut
Apr 2,2024 InhibitorsThe introduction of Metyltetraprole
Metyltetraprole was announced by Sumitomo Chemical Company as a new fungicide in 2017 and is, just like fenpicoxamid and florylpicoxamid, an inhibitor of cytochrome bc1 (complex III of the fungal res
Feb 5,2024 InhibitorsFluxapyroxad: Synthesis and Introduction
A preparation of fluxapyroxad is likely to involve a metal catalyzed cross coupling reaction to produce the key aniline intermediate 8.
Jan 31,2024 InhibitorsInfigratinib: Synthesis and Introduction
Infigratinib was synthesized in a modular and convergent fashion via the union of three building blocks.
Jan 29,2024 InhibitorsHow is Sotorasib synthesised?
The synthetic route of Sotorasib is completed in three steps, starting with the amidation of nicotinic acid derivatives to produce nicotinamide, obtaining acyl isomer purity 28.6 by classical resoluti
Jan 26,2024 Inhibitors